Farms.com Home   News

Health Canada Issues Notice Re: Antimicrobial Drugs

The following notice was issued by Health Canada regarding collaborative efforts to promote the judicious use of medically-important antimicrobial drugs in food animal production:

Antimicrobial resistance (AMR) is a complex and evolving public health issue, involving many players in Canada and internationally.  Health Canada's Veterinary Drugs Directorate (VDD) continues to promote the prudent use of antimicrobial drugs with the objective of minimizing the development and spread of AMR due to antimicrobial use in veterinary medicine and food animal production.

The VDD has been engaging provincial/territorial authorities, the pharmaceutical industry, veterinarians, food animal producers and other stakeholders to promote the judicious use of medically-important antimicrobial drugs in food animal production.

As part of these ongoing efforts, we are now moving forward, in collaboration with the Canadian Animal Health Institute (CAHI), to work with other implicated stakeholders on the following two key measures:

Removal of growth promotion and/or production claims of medically-important antimicrobial drugs
Development of options to strengthen the veterinary oversight of antimicrobial use in food animals.
Similar measures are being implemented in the United States over an anticipated three year transition. The VDD will continue to collaborate and align to the extent possible, for an efficient transition for all involved parties over the same time period.

Health Canada will consult impacted parties throughout the implementation of these two key measures in the Canadian context.

Source: AlbertaPork


Trending Video

Season 6, Episode 10: Defining Resiliency and the Research Driving Swine Health Forward

Video: Season 6, Episode 10: Defining Resiliency and the Research Driving Swine Health Forward

Genetic research and new technologies continue to influence the future of swine health and production efficiency. In this episode, we explore how research and technology are being used to support stronger, more resilient pigs, while also improving overall production outcomes. In this episode, we are joined by Dr. Jenelle Dunkelberger, geneticist with Topigs Norsvin, to discuss both routine and emerging strategies for improving piglet, pig, and sow livability. She outlines two primary approaches to enhancing resiliency: gene editing and traditional selective breeding. Continuing the resiliency conversation, we also hear from Dr. Lucina Galina, director of technical research projects at the Pig Improvement Company. She shares insights into ongoing gene-editing work focused on PRRS, detailing the pathway to success, regulatory and practical considerations, and the questions that still remain as the technology evolves. Together, these conversations provide a closer look at how research, genetics and innovation are shaping the future of swine health and livability.